Vincerx Pharma, Inc. (VINC)

Import this data to Google Sheets with:

=jivedata("VINC","financials")

Full statements spill as a table. For one cell: =jivedata("VINC","Revenue") or =jivedata("VINC","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Vincerx Pharma, Inc.

VINC • CIK 0001796129

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Operating Expenses	$73,574	$42,609	$31,463	$27,319
Operating Income (Loss)	$-73,574	$-42,609	$-31,463	$-27,319
Net Income (Loss) Attributable to Parent	$-65,367	$-40,157	$-30,074	$-22,645
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-65,372	$-40,123	$-29,963	$-22,535
Weighted Average Number of Shares Outstanding, Basic	21,029	21,295	1,898	-15,922
General and Administrative Expense	$18,953	$13,636	$15,977	$15,371
Research and Development Expense (Excluding Acquired in Process Cost)	$52,152	$28,973	$15,486	$11,948
Fair Value Adjustment of Warrants	$-6,303	$47	$-183	$-5,395
Investment Income, Interest	$664	$1,251	$472	$373
Other Nonoperating Income (Expense)	$1,240	$1,248	$734	$644
Nonoperating Income (Expense)	$8,207	$2,452	$1,389	$4,674
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	$69	$-40	$110	$109
Marketable Securities, Unrealized Gain (Loss)	$-74	$74	$1	$1

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Cash and Cash Equivalents, at Carrying Value	$11,663	$12,782	$4,987	$4,437
Restricted Cash, Current	$70	$72	$79	$82
Operating Lease, Right-of-Use Asset	$3,064	$2,201	$0	$0
Prepaid Expense, Current	$134	$51	$89	$123
Property, Plant and Equipment, Net	$177	$125	$0	$0
Grants Receivable, Current	—	$1,044	$1,041	$0
Other Assets, Noncurrent	$81	$1,158	$1,595	$1,595
Other Assets, Current	$3,301	$784	$214	$44
Assets	$59,286	$18,217	$8,005	$4,686
Assets, Current	$55,964	$14,733	$6,410	$4,686
Liabilities	$11,618	$6,995	$5,281	$2,620
Accounts Payable, Current	$3,065	$2,497	$2,029	$2,269
Accrued Liabilities, Current	$4,923	$1,755	$3,244	$351
Operating Lease, Liability, Current	$1,024	$1,162	$0	$0
Liabilities, Current	$9,156	$5,605	$5,281	$2,620
Operating Lease, Liability, Noncurrent	$2,412	$1,340	$0	$0
Other Liabilities, Noncurrent	$50	$50	$0	$0
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$2	$2	$0	$1
Additional Paid in Capital	$169,030	$170,324	$191,791	$196,081
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-26	$8	$119	$170
Retained Earnings (Accumulated Deficit)	$-121,338	$-159,112	$-189,186	$-194,186
Stockholders' Equity Attributable to Parent	$47,668	$11,222	$2,724	$2,066
Preferred Stock, Shares Authorized	30,000,000	30,000,000	30,000,000	30,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	120,000,000	120,000,000	120,000,000	120,000,000
Common Stock, Shares, Issued	21,242,884	21,407,510	2,239,580	5,234,277
Property, Plant and Equipment, Gross	$256	$256	$0	$0
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$79	$131	$0	$0
Accrued Salaries, Current	$297	$332	$144	$144
Accrued Employee Benefits, Current	$923	$918	$278	$278

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-65,367	$-40,157	$-30,074	$-22,645
Net Cash Provided by (Used in) Operating Activities	$-59,604	$-40,453	$-26,127	$-22,842
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$71	$-40	$135	$114
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-99,831	$1,121	$-7,788	$-673
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$11,733	$12,854	$5,066	$4,393
Depreciation, Depletion and Amortization	$54	$52	$52	$39
Payments to Acquire Marketable Securities	$42,978	$11,821	$11,463	$11,463
Employee Benefits and Share-based Compensation	$12,439	$3,563	$3,473	$3,380
Proceeds from Sale and Maturity of Marketable Securities	$2,400	$53,321	$11,675	$11,675
Operating Lease, Right-of-Use Asset, Amortization Expense	$885	$863	$1,038	$787
Net Cash Provided by (Used in) Investing Activities	$-40,578	$41,500	$212	$212
Gain (Loss) on Termination of Lease	—	—	$44	$44
Fair Value Adjustment of Warrants	$-6,303	$47	$-183	$-5,395
Accretion (Amortization) of Discounts and Premiums, Investments	$292	$630	$211	$211
Increase (Decrease) in Prepaid Expense	$3,158	$-1,228	$-532	$-1,293
Proceeds from Issuance Initial Public Offering	—	—	$15,713	$15,713
Increase (Decrease) in Other Operating Assets	$-1,572	$1,077	$519	$606
Proceeds from Stock Plans	$280	$114	$118	$113
Increase (Decrease) in Accounts Payable	$1,046	$-1,568	$-468	$-45
Net Cash Provided by (Used in) Financing Activities	$280	$114	$17,992	$21,843
Increase (Decrease) in Accrued Liabilities	$208	$-2,168	$1,489	$-1,376
Increase (Decrease) in Other Noncurrent Liabilities	$50	$0	$-50	$-50
Interest Paid, Excluding Capitalized Interest, Operating Activities	$0	$0	$0	$0

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("VINC","financials")

Full statements spill as a table. For one cell: =jivedata("VINC","Revenue") or =jivedata("VINC","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.